Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Gentile

Showing results (91-100 of 313) with videos related to

Pageof 32
Sort By:
Expert Opinion on Pharmacotherapy|March 19, 2024
Selinexor in multiple myelomaEnrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, et al.
European Journal of Haematology|October 13, 2024
Therapy-Related Acute Promyelocytic Leukemia: Case Series and Current InsightsAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
European Journal of Haematology|October 29, 2025
Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating AgentsErnesto Vigna, Antonella Bruzzese, Enrica Antonia Martino, et al.
Expert Review of Hematology|June 29, 2019
Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trialsMassimo Martino, Marco Rossi, Anna Ferreri, et al.
Hematological Oncology|February 28, 2009
CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLLLilla Cro, Fortunato Morabito, Nadia Zucal, et al.
Frontiers in Oncology|November 16, 2020
Heterogeneity of <i>TP53</i> Mutations and P53 Protein Residual Function in Cancer: Does It Matter?Paola Monti, Paola Menichini, Andrea Speciale, et al.
European Journal of Haematology|May 25, 2026
Frailty and Fitness in Older Adults With Acute Myeloid Leukemia: From Chronological Age to Multiparametric AssessmentAntonella Bruzzese, Enrica Antonia Martino, Santino Caserta, et al.
Expert Opinion on Biological Therapy|September 11, 2024
Mosunetuzumab for the treatment of follicular lymphomaCaterina Labanca, Enrica Antonia Martino, Ernesto Vigna, et al.
Frontiers in Oncology|July 7, 2020
Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib: A Case ReportCirino Botta, Nadia Caruso, Sabrina Bossio, et al.
The Journal of Investigative Dermatology|October 19, 2007
The multidrug transporter P-glycoprotein: a mediator of melanoma invasion?Marisa Colone, Annarica Calcabrini, Laura Toccacieli, et al.
Pageof 32

Showing results (91-100 of 313) with videos related to

Sort By:
Pageof 32
Expert Opinion on Pharmacotherapy|March 19, 2024
Selinexor in multiple myelomaEnrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, et al.
European Journal of Haematology|October 13, 2024
Therapy-Related Acute Promyelocytic Leukemia: Case Series and Current InsightsAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
European Journal of Haematology|October 29, 2025
Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating AgentsErnesto Vigna, Antonella Bruzzese, Enrica Antonia Martino, et al.
Expert Review of Hematology|June 29, 2019
Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trialsMassimo Martino, Marco Rossi, Anna Ferreri, et al.
Hematological Oncology|February 28, 2009
CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLLLilla Cro, Fortunato Morabito, Nadia Zucal, et al.
Frontiers in Oncology|November 16, 2020
Heterogeneity of <i>TP53</i> Mutations and P53 Protein Residual Function in Cancer: Does It Matter?Paola Monti, Paola Menichini, Andrea Speciale, et al.
European Journal of Haematology|May 25, 2026
Frailty and Fitness in Older Adults With Acute Myeloid Leukemia: From Chronological Age to Multiparametric AssessmentAntonella Bruzzese, Enrica Antonia Martino, Santino Caserta, et al.
Expert Opinion on Biological Therapy|September 11, 2024
Mosunetuzumab for the treatment of follicular lymphomaCaterina Labanca, Enrica Antonia Martino, Ernesto Vigna, et al.
Frontiers in Oncology|July 7, 2020
Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib: A Case ReportCirino Botta, Nadia Caruso, Sabrina Bossio, et al.
The Journal of Investigative Dermatology|October 19, 2007
The multidrug transporter P-glycoprotein: a mediator of melanoma invasion?Marisa Colone, Annarica Calcabrini, Laura Toccacieli, et al.
Pageof 32